Tuberculosis in elderly population: A cross-sectional comparative study

Background: Tuberculosis (TB) is a common but neglected infectious disease of global significance. It has a varied presentation in the elderly compared to adults. The present study was conceived to study the resemblances and differences shared in terms of clinical profile, comorbidities, and laboratory investigations by TB in adults and the elderly population. Methods: In this cross-sectional study, 68 adults and 72 elderly patients of both genders were enrolled. We collected information on demographics, comorbidities, clinical presentations, and laboratory investigations. The comparison of data between groups was done using the unpaired t-test for continuous variables and the Chi-square test for frequency distribution analysis. Results: The mean age of the adults and elderly population was 42.13 ± 10.7 years and 68.78 ± 7.62 years, respectively. The elderly TB group demonstrated loss of weight, appetite, the prevalence of comorbid conditions (coronary artery disease, hypertension, and malnutrition), bilateral, predominantly lower lobe, and diffuse involvement of lungs. Conclusion: As the elderly population increases, nonspecific clinical manifestations or laboratory results in this population mandate awareness of these atypical features for effective management of TB in this group.

[1]  V. Venketaraman,et al.  Mycobacterium tuberculosis: Implications of Ageing on Infection and Maintaining Protection in the Elderly , 2022, Vaccines.

[2]  K. Jacobson,et al.  The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms , 2022, Frontiers in Immunology.

[3]  S. Diamantis,et al.  Tuberculosis in the Elderly , 2021, Journal of clinical medicine.

[4]  Y. Woldeamanuel,et al.  Five-Year Trend Analysis of Tuberculosis in Bahir Dar, Northwest Ethiopia, 2015–2019 , 2021, International journal of mycobacteriology.

[5]  M. Andreoni,et al.  Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art , 2021, Microorganisms.

[6]  L. D. de Groot,et al.  Nutritional concerns later in life , 2021, Proceedings of the Nutrition Society.

[7]  J. Nachega,et al.  Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  Y. Jain,et al.  Geriatric population in India: Demography, vulnerabilities, and healthcare challenges , 2021, Journal of family medicine and primary care.

[9]  L. Telisinghe,et al.  Diagnosing Pulmonary Tuberculosis in the Elderly , 2020, Current Geriatrics Reports.

[10]  Dandan Zong,et al.  The role of cigarette smoke-induced epigenetic alterations in inflammation , 2019, Epigenetics & Chromatin.

[11]  O. Kon,et al.  Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review , 2019, ERJ Open Research.

[12]  Gemeda Abebe,et al.  Treatment outcomes and associated factors in tuberculosis patients at Jimma University Medical Center: A 5-year retrospective study , 2019, International journal of mycobacteriology.

[13]  D. Kimuli,et al.  Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda , 2018, PloS one.

[14]  C. Leung,et al.  Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people , 2018, Respirology.

[15]  Zied Gaifer Risk factors for tuberculosis mortality in a tertiary care center in Oman, 2006–2016 , 2017, International journal of mycobacteriology.

[16]  Haroon,et al.  Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study , 2017, International journal of mycobacteriology.

[17]  Zied Gaifer Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman , 2017, International journal of mycobacteriology.

[18]  Peter J Dodd,et al.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.

[19]  L. Almeida,et al.  Clinical presentation and mortality of tuberculosis in the elderly , 2016 .

[20]  J. Friedland,et al.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. , 2014, American journal of respiratory and critical care medicine.

[21]  N. Hochberg,et al.  Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Small,et al.  Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes. , 2012, Age and ageing.

[23]  Kathleen M. Akgün,et al.  Epidemiology and management of common pulmonary diseases in older persons. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  J. Kammerer,et al.  Tuberculosis in Older Adults in the United States, 1993–2008 , 2011, Journal of the American Geriatrics Society.

[25]  Philippe Glaziou,et al.  Tuberculosis control and elimination 2010–50: cure, care, and social development , 2010, The Lancet.

[26]  Daljit Singh,et al.  TUBERCULOSIS IN THE ELDERLY (AGED 50 YEARS AND ABOVE) AND THEIR TREATMENT OUTCOME UNDER DOTS , 2007 .

[27]  J. Song,et al.  Diagnostic and Therapeutic Problems of Pulmonary Tuberculosis in Elderly Patients , 2005, Journal of Korean medical science.